Actively Recruiting

Phase Not Applicable
Age: 40Years - 69Years
All Genders
NCT05725096

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

Led by Zhang longjiang,MD · Updated on 2024-11-26

3400

Participants Needed

1

Research Sites

204 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy improves lipid-lowering treatment and cardiovascular risk factor control compared with traditional CHD prevention strategy, guided by a cardiovascular risk score.

CONDITIONS

Official Title

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population

Who Can Participate

Age: 40Years - 69Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Nanjing residents who have no plans to leave in the next 5 years
  • Aged from 40 to 69 years
  • Free of any known clinically cardiovascular disease
  • Able to comprehend and sign an informed consent form
Not Eligible

You will not qualify if you...

  • Serious liver dysfunction, defined as AST or ALT > 3 times the normal upper limit
  • Chronic kidney disease (CKD) > stage 4, defined as eGFR < 30 ml/min/1.73 m2
  • Prior CCTA or invasive coronary angiography within the last 5 years
  • Any contraindications for CCTA
  • Previous use of statin or non-statin lipid-lowering medication (such as ezetimibe, PCSK9 inhibitor and XueZhiKang)
  • Life expectancy < 3 years
  • Other reasons the researcher deems inappropriate to attend

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Research Institute Of Medical Imaging Jinling Hospital

Nanjing, Jiangsu, China, 210018

Actively Recruiting

Loading map...

Research Team

L

Longjiang Zhang, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population | DecenTrialz